Uncategorized

FDA Issues Safety Warning Regarding Neck Float Devices for Babies

August 18, 2022
Posted in

On June 28,2022, the U.S. Food and Drug Administration (FDA) issued a safety communication about using neck float with babies. This occurs when a serious […]

Read More ›

Cure SMA Publishes Results from Survey Measuring Disease Burden in Adolescents and Young Adults

August 15, 2022
Posted in

As treatment options increase for adolescents and young adults living with SMA, we need tools to measure the effectiveness of these treatments from the patient’s […]

Read More ›

Cure SMA Publishes Research Exploring What Is Important to SMA Clinical Trial Participants

August 15, 2022
Posted in

The recent availability of new treatments for SMA would not have been possible without the participation of SMA-affected individuals in clinical trials. Yet participating in […]

Read More ›

Financial Planning with a Disability

June 17, 2021
Posted in

When you first learned that you or your child had SMA, you probably began analyzing your home life, your or your child’s education, and other […]

Read More ›

Community Spotlight: Nikki McIntosh

November 25, 2020
Posted in , ,

Nikki McIntosh is known as the founder of Rare Mamas, an online resource that supports and empowers mothers who have children with rare diseases. She […]

Read More ›

Community Spotlight: Scurria Family

December 20, 2019
Posted in , ,

John and Krista Scurria, of Baton Rouge, La., believe in a parent’s intuition. Krista first became worried about the development of her oldest child, Josh, […]

Read More ›

2019 SMA Researcher Meeting Summary: Clinical Drug Development

September 12, 2019
Posted in

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 […]

Read More ›

What to Expect in a Clinical Trial

September 4, 2018
Posted in

Clinical trials for spinal muscular atrophy (SMA) help researchers answer important questions about the disease and investigational drugs, providing information that may help the development […]

Read More ›

Cure SMA Statement on Tax Reform Bill and the Repeal of the Individual Mandate

December 21, 2017
Posted in

On Wednesday, Congress passed the most sweeping tax bill in a generation. Cure SMA has been monitoring and advocating on your behalf as this legislation […]

Read More ›

Cure SMA Announces $5.05 Million in Research Funding for FY18

September 19, 2017
Posted in

Over the past fiscal year—from July 1, 2016, to June 30, 2017—Cure SMA has funded over $2.5 million in new research funding. This funding will […]

Read More ›
Scroll to Top